| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/27/2011 | CN101143207B Application of natural type, breaking type or No. 5 domain delation variant type beta 2 glycoprotein I in preparing medicine for inhibiting blood vessel newborn |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2465103C Use of a prostaglandin derivative as an anti-pruritic agent |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2423628C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2402597C Composition for use in treatment of ocular hypertension and glaucoma |
| 04/26/2011 | CA2364948C C16 unsaturated fp-selective prostaglandins analogs |
| 04/21/2011 | WO2011046239A1 Novel usage of imidazole compound |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011045594A1 Novel macrocycles and methods for their production |
| 04/21/2011 | WO2011045593A1 Novel macrocyles and methods for their production |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2010117997A3 Peptide targeting of inner ear cells |
| 04/21/2011 | WO2010059846A3 Sulfonamide inhibitors of carbonic anhydrase ii |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092596 Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| 04/21/2011 | US20110092590 Nitric oxide donating prostamides |
| 04/21/2011 | US20110092583 Oral Dosage Form Of Tetrahydrocannabinol And A Method Of Avoiding And/Or Suppressing Hepatic First Pass Metabolism Via Targeted Chylomicron/Lipoprotein Delivery |
| 04/21/2011 | US20110092537 2,6-Diaminopyridine Compounds Suitable For Treating Diseases Associated With Amyloid Or Amyloid-Like Proteins Or For Treating Or Preventing Ocular Diseases Or Conditions Associated With A Pathological Abnormality/Change In The Tissue Of The Visual System |
| 04/21/2011 | US20110092524 Agent for Enhancing Corneal Epithelial Barrier Function |
| 04/21/2011 | US20110092523 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| 04/21/2011 | US20110092509 Pharmaceutical Composition for Prevention or Treatment of Disease Associated with Tear Reduction |
| 04/21/2011 | US20110092502 Diaminothiazoles useful as axl inhibitors |
| 04/21/2011 | US20110092500 Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment |
| 04/21/2011 | US20110092478 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092471 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 04/21/2011 | US20110091520 Sustained Release Intraocular Implants and Methods for Treating Ocular Neuropathies |
| 04/21/2011 | US20110091474 Compositions and Methods For Diagnosing and Treating Diabetic Micro Vascular Complications |
| 04/21/2011 | US20110091468 Connective tissue growth factor antibodies |
| 04/21/2011 | US20110091459 Imidazole modulators of muscarinic acetylcholine receptor m3 |
| 04/21/2011 | CA2777509A1 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311949A2 Antisense compounds targeted to connexins and methods of use thereof |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311823A1 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311494A1 Histone modification inhibitor specific to target gene |
| 04/20/2011 | EP2311484A1 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 04/20/2011 | EP2311465A1 Remedies for diseases to be applied to eye |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310038A2 Treatment of hearing and balance impairments using compounds having erythropoietin activity |
| 04/20/2011 | EP2310034A2 Compounds for treating beta-amyloidoses |
| 04/20/2011 | EP2310008A2 Ph specific solutions of sodium mycophenolic acid for the treatment of eye disorders |
| 04/20/2011 | EP2061444B1 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 04/20/2011 | EP2027082B1 12-aryl prostaglandin analogs |
| 04/20/2011 | EP1392319B1 Hypotensive lipid (prostaglandin) and timolol compositions and methods of using same |
| 04/20/2011 | EP1082415B1 Methods useful for modulation of angiogenesis using tyrosine kinase src |
| 04/20/2011 | CN1946384B Statins for the treatment of ocular hypertension and glaucoma |
| 04/20/2011 | CN1943650B Rose liquid eye drops |
| 04/20/2011 | CN1836667B Eye drop |
| 04/20/2011 | CN102026648A Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders |
| 04/20/2011 | CN102026640A sGC stimulators, sGC activators and combinations thereof for the treatment of hearing impairment |
| 04/20/2011 | CN102026633A 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 04/20/2011 | CN102026623A Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 04/20/2011 | CN102018949A Traditional Chinese medicine composition for treating vertigo |
| 04/20/2011 | CN102018865A Chinese medicinal composition for treating deaf |
| 04/20/2011 | CN102018830A Traditional Chinese medicine for treating fundus hemorrhage |
| 04/20/2011 | CN102018789A Traditional Chinese medicine composition for alleviating asthenopia and preparation method thereof |
| 04/20/2011 | CN102018785A Traditional Chinese medicine for treating diabetes fundus lesions |
| 04/20/2011 | CN102018757A Traditional Chinese medicine for treating eyeground pathological changes caused by diabetes |
| 04/20/2011 | CN102018736A Natural indigo decoction piece and preparation method thereof |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018656A Eye gel containing latanoprost used as effective component and preparation method thereof |
| 04/20/2011 | CN101695554B Chinese medicament for treating myopia |
| 04/20/2011 | CN101612382B Method for detecting medicine quality of xianzhixuanning traditional Chinese medicine preparation |
| 04/20/2011 | CN101560178B Polysubstituted indoline compound, preparation method and medical application thereof |
| 04/20/2011 | CN101530502B Traditional Chinese medicine for treating diabetic fundus hemorrhage |
| 04/20/2011 | CN101417971B Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/20/2011 | CN101357177B Traditional Chinese medicine for preventing and treating central serous chorioretinopathy and preparation method thereof |
| 04/20/2011 | CN101015567B Medicine composition for treating ophthalmological diseases and preparing process thereof and quality control method |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2621181C 5-isoquinolinesulfonamide compounds |
| 04/19/2011 | CA2596241C Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 04/16/2011 | CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011021203A3 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 04/14/2011 | WO2010093873A3 Drug delivery through hydrogel plugs |
| 04/14/2011 | US20110086916 Interval therapy for the treatment of tinnitus |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086849 novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and ause thereof |
| 04/14/2011 | US20110086847 Thiadiazole modulators of beta adrenergic receptor |
| 04/14/2011 | US20110086815 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 04/14/2011 | US20110086807 Fibromodulin formulation for reducing corneal scarring |
| 04/14/2011 | US20110086802 Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network |
| 04/14/2011 | US20110086002 Restoration of hearing loss |